AA
AlphaCentric Advisors’s GSK GSK Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-35,000
| Closed | -$1.43M | – | 246 |
|
2024
Q3 | $1.43M | Hold |
35,000
| – | – | 1.06% | 31 |
|
2024
Q2 | $1.35M | Hold |
35,000
| – | – | 0.99% | 32 |
|
2024
Q1 | $1.5M | Hold |
35,000
| – | – | 0.91% | 38 |
|
2023
Q4 | $1.3M | Sell |
35,000
-15,000
| -30% | -$556K | 0.87% | 42 |
|
2023
Q3 | $1.81M | Hold |
50,000
| – | – | 1.03% | 31 |
|
2023
Q2 | $1.78M | Sell |
50,000
-30,000
| -38% | -$1.07M | 0.99% | 35 |
|
2023
Q1 | $2.85M | Buy |
80,000
+19,000
| +31% | +$676K | 1.96% | 7 |
|
2022
Q4 | $2.14M | Sell |
61,000
-9,000
| -13% | -$316K | 2.12% | 4 |
|
2022
Q3 | $2.06M | Buy |
+70,000
| New | +$2.06M | 2.11% | 8 |
|
2021
Q2 | – | Sell |
-10,000
| Closed | -$357K | – | 224 |
|
2021
Q1 | $357K | Buy |
10,000
+7,900
| +376% | +$282K | 0.12% | 65 |
|
2020
Q4 | $77K | Buy |
2,100
+1,900
| +950% | +$69.7K | 0.03% | 158 |
|
2020
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 159 |
|
2020
Q2 | $8K | Buy |
+200
| New | +$8K | ﹤0.01% | 138 |
|